At Amsterdam Airport delegates representing the local CRO associations from the Netherlands, Germany, Czech Republic, France, Spain, Italy and United Kingdom were represented for the inaugural meeting of the European CRO Federation (EUCROF).
On Wednesday 19 October 2005 the European CRO Federation was founded.
At Amsterdam Airport delegates representing the local CRO associations from the Netherlands, Germany, Czech Republic, France, Spain, Italy and United Kingdom were represented for the inaugural meeting of the European CRO Federation (EUCROF).
The aims and objectives of EUCROF were defined as:
The first elected President of EUCROF is Mr. Pieter Guelen from ACRON (The Netherlands). As Vice-President Mrs. Dagmar Chase from BVMA (Germany) was elected. Mr. Dominique Gerbet from AFCROs (France) was elected as treasurer and Mr. Jos Garcia from AECIC (Spain) was elected as general board member. The Federation will be established in the Netherlands.
Members of EUCROF are national associations of Clinical Research Organisations (CROs). The current 7 associations are representative of the local CROs network and represent as of today 250 companies.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.